Literature DB >> 15028314

The role of staging investigations for oesophago-gastric carcinoma.

D M Clements1, D J Bowrey, T J Havard.   

Abstract

AIMS: To study the frequency with which unresectable disease was identified on pre-operative staging investigations in patients with oesophago-gastric carcinoma, and to audit whether a staging protocol had reduced the rate of exploratory surgery.
METHODS: Ninety-eight patients with oesophageal carcinoma, 89 patients with adenocarcinoma of the gastro-oesophageal junction (GOJ) and 68 patients with gastric carcinoma were staged according to a protocol of computerised tomography, laparoscopy and endoscopic ultrasound.
RESULTS: The frequency with which each investigation identified unresectable disease was as follows: (a) computerised tomography-oesophagus 12/67, GOJ 13/58, stomach 10/60; (b) laparoscopy-oesophagus 3/22, GOJ 5/45, stomach 8/23; and (c) endoscopic ultrasound-oesophagus 15/55, GOJ 3/30. By tumour location, rates of exploratory surgery were 1/18 for the oesophagus, 12/35 for the GOJ and 4/42 for the stomach. All of the staging failures in patients with GOJ carcinomas related to posterior tumour extension into the lesser sac.
CONCLUSIONS: Staging investigations precluded resection in one-third of patients, the greatest yield being for laparoscopy in gastric carcinoma. In spite of this, 18% of patients undergoing surgical intervention underwent exploratory surgery alone, notably patients with GOJ carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 15028314     DOI: 10.1016/j.ejso.2003.11.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

Review 1.  [Staging laparoscopy in oncology].

Authors:  H Feussner; F Härtl
Journal:  Chirurg       Date:  2006-11       Impact factor: 0.955

2.  Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.

Authors:  Henderik L van Westreenen; Pierre A M Heeren; Hendrik M van Dullemen; Eric J van der Jagt; Pieter L Jager; Henk Groen; John Th M Plukker
Journal:  J Gastrointest Surg       Date:  2005-01       Impact factor: 3.452

3.  Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

Authors:  L M A Schreurs; A C J W Janssens; H Groen; P Fockens; H M van Dullemen; M I van Berge Henegouwen; G W Sloof; J Pruim; J J B van Lanschot; E W Steyerberg; J Th M Plukker
Journal:  Ann Surg Oncol       Date:  2011-05-06       Impact factor: 5.344

4.  Patients' perception of diagnostic tests in the preoperative assessment of esophageal cancer.

Authors:  Marinke Westerterp; Henderik L van Westreenen; Marije Deutekom; Jaap Stoker; Paul Fockens; Emile Fi Comans; John Tm Plukker; Patrick Mm Bossuyt; J Jan B van Lanschot; Gerrit W Sloof
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

Review 5.  Role of laparoscopy in hepatobiliary malignancies.

Authors:  Prabhu Arumugam; Vickna Balarajah; Jennifer Watt; Ajit T Abraham; Satyajit Bhattacharya; Hemant M Kocher
Journal:  Indian J Med Res       Date:  2016-04       Impact factor: 2.375

6.  Risk of Confusion: Detection of a Circular Thickness of the Wall in the Lower Part of the Esophagus.

Authors:  Achim Hochlehnert; Sylvie Lorenzen; Peter Hallscheidt; Jens Encke; Robert Ehehalt
Journal:  Gastroenterology Res       Date:  2011-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.